Geisinger Health System

Booming Field

CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.

Among the initial crop of products there may not be a killer app yet, but these first offerings will enable Helix and partners to begin to understand their customer base.

A curation working group established a framework that considers the nature and strength of the available evidence when evaluating gene-disease associations.

Separate studies in NEJM from Regeneron Pharmaceuticals and Ionis Pharmaceuticals target the ANGPTL3 gene in an effort to develop heart disease treatments.

Penn State University has established a new program to train graduate students to apply data science to biomedical sciences, including genomics.

Respondents to a 2013 survey described changes in the way hereditary breast and ovarian cancer risk is assessed, interpreted, and conveyed to patients following the court decision.

As part of a wrongful termination suit, a couple accuses Geisinger Health System of coercing patients to take part in genetic studies.

The DiscovEHR study, conducted by the Regeneron Genetics Center and the Geisinger Health System, uncovered many associations between genetic variants and clinical phenotypes.

The healthcare provider organizations are tasked with managing patient enrollment in the Precision Medicine Initiative.

The Pharmacogenomics Clinical Annotation Tool interprets variants from sequencing or genotyping tests and generates a report to inform prescribing decisions.

Pages

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.